Vaccines, Blood & Biologics

AFSTYLA

STN#: BL 125591
Proper Name: Antihemophilic Factor (Recombinant), Single Chain
Tradename: AFSTYLA
Manufacturer: CSL Behring, LLC 
Indication: 

  • Indicated in adults and children with hemophilia A (congenital Factor VIII deficiency) for: (1) On-demand treatment and control of bleeding episodes, (2) Routine prophylaxis to reduce the frequency of bleeding episodes, and (3) Perioperative management of bleeding.

Contact FDA

(800) 835-4709
(240) 402-8010
Consumer Affairs Branch (CBER)

Division of Communication and Consumer Affairs

Office of Communication, Outreach and Development

Food and Drug Administration

10903 New Hampshire Avenue

Building 71 Room 3103

Silver Spring, MD 20993-0002

Page Last Updated: 02/20/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English